The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Sugiyama, T., Kohara, H., Noda, M., & Nagasawa, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.016 · Cited by 2,412
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life
Morrison, S. J., & Spradling, A. C. (2008) · Cell · doi:10.1016/j.cell.2008.01.038 · Cited by 1,955
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9448 · Cited by 1,682
Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.-L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J.-M., Clark-Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Self-citationMoore, K. A., & Lemischka, I. R. (2006) · Science · doi:10.1126/science.1110542 · Cited by 1,553
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4
Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., et al. (2002) · Nature Immunology · doi:10.1038/ni813 · Cited by 1,332
Self-citationLymphocyte traffic control by chemokines
Moser, B., & Loetscher, P. (2001) · Nature Immunology · doi:10.1038/84219 · Cited by 1,240
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
Self-citationBroxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041385 · Cited by 970
Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A., & Dalton, W. S. (1999) · Blood · doi:10.1182/blood.v93.5.1658 · Cited by 901
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Côté, D., Means, T. K., Luster, A. D., Scadden, D. T., & Lin, C. P. (2005) · Nature · doi:10.1038/nature03703 · Cited by 878
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870
Molecular cloning and structure of a pre-B-cell growth-stimulating factor.
Nagasawa, T., Kikutani, H., & Kishimoto, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2305 · Cited by 803
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
Allen, C. D. C., Ansel, K. M., Low, C., Lesley, R., Tamamura, H., Fujii, N., & Cyster, J. G. (2004) · Nature Immunology · doi:10.1038/ni1100 · Cited by 802
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
Orimo, A., & Weinberg, R. A. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3112 · Cited by 799
Abbott, J. D., Huang, Y., Liu, D., Hickey, R., Krause, D. S., & Giordano, F. J. (2004) · Circulation · doi:10.1161/01.cir.0000147780.30124.cf · Cited by 783
Martin, C., Burdon, P. C. E., Bridger, G., Gutierrez-Ramos, J.-C., Williams, T. J., & Rankin, S. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00263-2 · Cited by 770
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R., et al. (1999) · Nature Medicine · doi:10.1038/9511 · Cited by 739
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
Liles, W. C., Broxmeyer, H. E., Rodger, E., Wood, B., Hübel, K., Cooper, S., Hangoc, G., Bridger, G. J., Henson, G. W., Calandra, G., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0663 · Cited by 718
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements
Hargreaves, D. C., Hyman, P. L., Lu, T. T., Ngo, V. N., Bidgol, A., Suzuki, G., Zou, Y.-R., Littman, D. R., & Cyster, J. G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.45 · Cited by 659
CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4
Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S., Vance, P. J., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81393-8 · Cited by 655
Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R. M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702229104 · Cited by 624
Control of Chemokine-Guided Cell Migration by Ligand Sequestration
Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Wilson, D., Xu, Q., & Raz, E. (2008) · Cell · doi:10.1016/j.cell.2007.12.034 · Cited by 622
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 607
Self-citationMa, Q., Jones, D., & Springer, T. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80046-1 · Cited by 583
Matsunaga, T., Takemoto, N., Sato, T., Takimoto, R., Tanaka, I., Fujimi, A., Akiyama, T., Kuroda, H., Kawano, Y., Kobune, M., et al. (2003) · Nature Medicine · doi:10.1038/nm909 · Cited by 563
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines
Wright, D. E., Bowman, E. P., Wagers, A. J., Butcher, E. C., & Weissman, I. L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011284 · Cited by 517
Burger, J. A., Burger, M., & Kipps, T. J. (1999) · Blood · doi:10.1182/blood.v94.11.3658 · Cited by 507
Self-citationHendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., & Henson, G. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1667-1673.2000 · Cited by 504
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma
Alsayed, Y., Ngo, H., Runnels, J., Leleu, X., Singha, U. K., Pitsillides, C. M., Spencer, J. A., Kimlinger, T., Ghobrial, J. M., Jia, X., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035857 · Cited by 478
Microenvironmental niches in the bone marrow required for B-cell development
Nagasawa, T. (2006) · Nature Reviews Immunology · doi:10.1038/nri1780 · Cited by 477
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
De Clercq, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1134 · Cited by 460
Phillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 455
Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Masui, T., Fujimoto, K., Tamamura, H., Hiramatsu, K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.29.3.1 · Cited by 407
Ramasamy, R., Lam, E. W.-F., Soeiro, I., Tisato, V, Bonnet, D., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404489 · Cited by 404
A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection
Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1389 · Cited by 398
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins
Konopleva, M., Konoplev, S., Hu, W., Zaritskey, A., Afanasiev, B., & Andreeff, M. (2002) · Leukemia · doi:10.1038/sj.leu.2402608 · Cited by 389
Segers, V. F. M., Tokunou, T., Higgins, L. J., MacGillivray, C., Gannon, J., & Lee, R. T. (2007) · Circulation · doi:10.1161/circulationaha.107.718718 · Cited by 376
Devine, S. M., Flomenberg, N., Vesole, D. H., Liesveld, J., Weisdorf, D., Badel, K., Calandra, G., & DiPersio, J. F. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.131 · Cited by 368
Hendrix, C. W., Collier, A. C., Lederman, M. M., Schols, D., Pollard, R. B., Brown, S., Jackson, J. B., Coombs, R. W., Glesby, M. J., Flexner, C. W., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000137371.80695.ef · Cited by 366
Tavor, S., Petit, I., Porozov, S., Avigdor, A., Dar, A., Leider-Trejo, L., Shemtov, N., Deutsch, V., Naparstek, E., Nagler, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3693 · Cited by 363
Marchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., & Allavena, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1343 · Cited by 339
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Iwamoto, S., Mihara, K., Downing, J. R., Pui, C.-H., & Campana, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30235 · Cited by 336
Doranz, B. J., Grovit-Ferbas, K., Sharron, M. P., Mao, S.-H., Goetz, M. B., Daar, E. S., Doms, R. W., & O'Brien, W. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1395 · Cited by 336
Stem Cell Trafficking in Tissue Development, Growth, and Disease
Laird, D. J., von Andrian, U. H., & Wagers, A. J. (2008) · Cell · doi:10.1016/j.cell.2008.01.041 · Cited by 330
CXCR4 is a prognostic marker in acute myelogenous leukemia
Spoo, A. C., Lübbert, M., Wierda, W. G., & Burger, J. A. (2007) · Blood · doi:10.1182/blood-2006-05-024844 · Cited by 330
Self-citationD'Apuzzo, M., Rolink, A., Loetscher, M., Hoxie, J. A., Clark‐Lewis, I., Melchers, F., Baggiolini, M., & Moser, B. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270729 · Cited by 327
Hu, X., Dai, S., Wu, W.-J., Tan, W., Zhu, X., Mu, J., Guo, Y., Bolli, R., & Rokosh, G. (2007) · Circulation · doi:10.1161/circulationaha.106.672451 · Cited by 319
Tamamura, H., Xu, Y., Hattori, T., Zhang, X., Arakaki, R., Kanbara, K., Omagari, A., Otaka, A., Ibuka, T., Yamamoto, N., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9871 · Cited by 308
Libura, J., Drukala, J., Majka, M., Tomescu, O., Navenot, J. M., Kucia, M., Marquez, L., Peiper, S. C., Barr, F. G., Janowska-Wieczorek, A., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0031 · Cited by 306
De Clercq, E., Yamamoto, N., Pauwels, R., Balzarini, J., Witvrouw, M., De Vreese, K., Debyser, Z., Rosenwirth, B., Peichl, P., & Datema, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.668 · Cited by 296
Burger, M., Hartmann, T., Krome, M., Rawluk, J., Tamamura, H., Fujii, N., Kipps, T. J., & Burger, J. A. (2005) · Blood · doi:10.1182/blood-2004-12-4918 · Cited by 295
Self-citationTamamura, H., Hori, A., Kanzaki, N., Hiramatsu, K., Mizumoto, M., Nakashima, H., Yamamoto, N., Otaka, A., & Fujii, N. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00824-x · Cited by 285
Hartmann, T. N., Burger, J. A., Glodek, A., Fujii, N., & Burger, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208621 · Cited by 280
Self-citationKijima, T., Maulik, G., Ma, P. C., Tibaldi, E. V., Turner, R. E., Rollins, B. J., Sattler, M., Johnson, B. E., & Salgia, R. (2002) · PubMed · Cited by 273
Rombouts, E. J. C., Pavic, B., Löwenberg, B., & Ploemacher, R. E. (2004) · Blood · doi:10.1182/blood-2004-02-0566 · Cited by 272
CXCL12-CXCR4 Engagement Is Required for Migration of Cutaneous Dendritic Cells
Kabashima, K., Shiraishi, N., Sugita, K., Mori, T., Onoue, A., Kobayashi, M., Sakabe, J.-I., Yoshiki, R., Tamamura, H., Fujii, N., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070225 · Cited by 268
Burger, M., Glodek, A., Hartmann, T., Schmitt-Gräff, A., Silberstein, L. E., Fujii, N., Kipps, T. J., & Burger, J. A. (2003) · Oncogene · doi:10.1038/sj.onc.1207097 · Cited by 267
Self-citationZagzag, D., Krishnamachary, B., Yee, H., Okuyama, H., Chiriboga, L., Ali, M. A., Melamed, J., & Semenza, G. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4406 · Cited by 260
Kim, S. Y., Lee, C. H., Midura, B. V., Yeung, C., Mendoza, A., Hong, S. H., Ren, L., Wong, D., Korz, W., Merzouk, A., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9133-3 · Cited by 253
Zhang, W.-B., Navenot, J.-M., Haribabu, B., Tamamura, H., Hiramatu, K., Omagari, A., Pei, G., Manfredi, J. P., Fujii, N., Broach, J. R., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200889200 · Cited by 247
Hamada, T., Möhle, R., Hesselgesser, J., Hoxie, J., Nachman, R. L., Moore, M. A. S., & Rafii, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.539 · Cited by 243
De Clercq, E., Yamamoto, N., Pauwels, R., Baba, M., Schols, D., Nakashima, H., Balzarini, J., Debyser, Z., Murrer, B. A., & Schwartz, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5286 · Cited by 242
Role of the CXCL12/CXCR4 Axis in Peritoneal Carcinomatosis of Gastric Cancer
Yasumoto, K., Koizumi, K., Kawashima, A., Saitoh, Y., Arita, Y., Shinohara, K., Minami, T., Nakayama, T., Sakurai, H., Takahashi, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3393 · Cited by 221
Activation of the hedgehog pathway in advanced prostate cancer.
Mori, T., Doi, R., Koizumi, M., et al. (2004) · PubMed · doi:10.1186/1476-4598-3-29 · Cited by 221
Fricker, S. P., Anastassov, V., Cox, J., Darkes, M. C., Grujic, O., Idzan, S. R., Labrecque, J., Lau, G., Mosi, R. M., Nelson, K. L., et al. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.05.010 · Cited by 215
Homing of antibody secreting cells
Cyster, J. G. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00041.x · Cited by 210
Zannettino, A. C. W., Farrugia, A. N., Kortesidis, A., Manavis, J., To, L. B., Martin, S. K., Diamond, P., Tamamura, H., Lapidot, T., Fujii, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1687 · Cited by 205
Farzan, M., Babcock, G. J., Vasilieva, N., Wright, P. L., Kiprilov, E., Mirzabekov, T., & Choe, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203361200 · Cited by 204
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.
Bertolini, F., Dell’Agnola, C., Mancuso, P., Rabascio, C., Burlini, A., Monestiroli, S., Gobbi, A., Pruneri, G., & Martinelli, G. (2002) · PubMed · Cited by 204
Burger, J. A., Zvaifler, N. J., Tsukada, N., Firestein, G. S., & Kipps, T. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11092 · Cited by 190
Self-citationAn attractive force in metastasis
Liotta, L. A. (2001) · Nature · doi:10.1038/35065180 · Cited by 185
Möhle, R., Failenschmid, C., Bautz, F., & Kanz, L. (1999) · Leukemia · doi:10.1038/sj.leu.2401602 · Cited by 184
Zeng, Z., Samudio, I. J., Munsell, M., An, J., Huang, Z., Estey, E., Andreeff, M., & Konopleva, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0228 · Cited by 184
Ara, T., Itoi, M., Kawabata, K., Egawa, T., Tokoyoda, K., Sugiyama, T., Fujii, N., Amagai, T., & Nagasawa, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4649 · Cited by 183
Ohlsson, L. B., Varas, L., Kjellman, C., Edvardsen, K., & Lindvall, M. (2003) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2003.06.001 · Cited by 182
CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins
Engl, T., Relja, B., Marian, D., Blumenberg, C., Müller, I., Beecken, W.-D., Jones, J., Ringel, E. M., Bereiter-Hahn, J., Jonas, D., et al. (2006) · Neoplasia · doi:10.1593/neo.05694 · Cited by 179
Chemokines and Their Receptors in Lymphocyte Traffic and HIV Infection
Loetscher, P., Moser, B., & Baggiolini, M. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60910-4 · Cited by 176
Ottaiano, A., Franco, R., Aiello Talamanca, A., Liguori, G., Tatangelo, F., Delrio, P., Nasti, G., Barletta, E., Facchini, G., Daniele, B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2142 · Cited by 171
Nakashima, H., Masuda, M., Murakami, T., Koyanagi, Y., Matsumoto, A., Fujii, N., & Yamamoto, N. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.6.1249 · Cited by 162
Burger, J. A., & Bürkle, A. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06590.x · Cited by 161
Self-citationKonoplev, S. N., Rassidakis, G. Z., Estey, E. H., Kantarjian, H. M., Liakou, C. I., Huang, X., Xiao, L., Andreeff, M., Konopleva, M. Y., & Medeiros, L. J. (2007) · Cancer · doi:10.1002/cncr.22510 · Cited by 160
Antigenically Distinct Conformations of CXCR4
Baribaud, F., Edwards, T. G., Sharron, M. P., Brelot, A., Heveker, N., Price, K., Mortari, F., Alizon, M., Tsang, M., & Doms, R. W. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.8957-8967.2001 · Cited by 159
Tumor microenvironment and drug resistance in hematologic malignancies
Li, Z., & Dalton, W. S. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.08.003 · Cited by 158
Cabıoğlu, N., Summy, J. M., Miller, C. P., Parikh, N. U., Şahin, A. A., Tuzlalı, S., Pumiglia, K. M., Gallick, G. E., & Price, J. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1303 · Cited by 157
Ichiyama, K., Yokoyama-Kumakura, S., Tanaka, Y., Tanaka, R. J., Hirose, K., Bannai, K., Edamatsu, T., Yanaka, M., Niitani, Y., Miyano‐Kurosaki, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630420100 · Cited by 156
Hit 'Em Where They Live: Targeting the Cancer Stem Cell Niche
Yang, Z.-J., & Wechsler‐Reya, R. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.007 · Cited by 154
Möhle, R., Schittenhelm, M. M., Failenschmid, C., Bautz, F., Kratz‐Albers, K., Serve, H. L., Brugger, W., & Kanz, L. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02157.x · Cited by 148
Maestroni, G. J. M., Hertens, E., & Gallì, P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050322 · Cited by 140
Spiegel, A., Kollet, Ó., Peled, A., Abel, L., Nagler, A., Bielorai, B., Rechavi, G., Vormoor, J. H., & Lapidot, T. (2003) · Blood · doi:10.1182/blood-2003-06-1891 · Cited by 139
Self-citationIdentification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent
Tamamura, H., Fujisawa, M., Hiramatsu, K., Mizumoto, M., Nakashima, H., Yamamoto, N., Otaka, A., & Fujii, N. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.056 · Cited by 137
Shen, W., Bendall, L. J., Gottlieb, D. J., & Bradstock, K. F. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00741-x · Cited by 134
Stone, N. D., Dunaway, S. B., Flexner, C. W., Tierney, C., Calandra, G., Becker, S. L., Cao, Y.-J., Wiggins, I. P., Conley, J., MacFarland, R. T., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00013-07 · Cited by 134
Honczarenko, M., Douglas, R. S., Mathias, C., Lee, B., Ratajczak, M. Z., & Silberstein, L. E. (1999) · Blood · doi:10.1182/blood.v94.9.2990 · Cited by 133
Human Melanoma Metastases Express Functional CXCR4
Scala, S., Giuliano, P., Ascierto, P. A., Ieranò, C., Franco, R., Napolitano, M., Ottaiano, A., Lombardi, M. L., Luongo, M., Simeone, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1940 · Cited by 131
A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)
Masuda, M., Nakashima, H., Ueda, T., Naba, H., Ikoma, R., Otaka, A., Terakawa, Y., Tamamura, H., Ibuka, T., Murakami, T., et al. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92280-b · Cited by 130
SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion
Hong, X., Jiang, F., Kalkanis, S. N., Zhang, Z. G., Zhang, X.-P., deCarvalho, A. C., Katakowski, M., Bobbitt, K. R., Mikkelsen, T., & Chopp, M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.011 · Cited by 124
Ohira, S., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Isse, K., Kozaka, K., Ishikawa, A., Oda, K., Nimura, Y., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050204 · Cited by 120
Abraham, M., Biyder, K., Begin, M., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0161 · Cited by 115
Lipid Bilayer Simulations of CXCR4 with Inverse Agonists and Weak Partial Agonists
Trent, J. O., Wang, Z., Murray, J. L., Shao, W.-H., Tamamura, H., Fujii, N., & Peiper, S. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307850200 · Cited by 114
Safe Use of the CXCR4 Inhibitor ALX40-4C in Humans
Doranz, B. J., Filion, L. G., Díaz‐Mitoma, F., SITAR, D. S., Sahai, J. V., Baribaud, F., Orsini, M. J., Benovic, J., Cameron, D. W., & Doms, R. W. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126508 · Cited by 112
Bradstock, K. F., Makrynikola, V., Bianchi, A., Shen, W., Hewson, J. W., & Gottlieb, D. J. (2000) · Leukemia · doi:10.1038/sj.leu.2401729 · Cited by 104
Human acute myeloid leukemia stem cells
Hope, K. J., Jin, L., & Dick, J. E. (2003) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.08.007 · Cited by 103
Kohara, H., Omatsu, Y., Sugiyama, T., Noda, M., Fujii, N., & Nagasawa, T. (2007) · Blood · doi:10.1182/blood-2007-04-084210 · Cited by 94
Burger, J. A., Spoo, A. C., Dwenger, A., Burger, M., & Behringer, D. M. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04466.x · Cited by 79
Self-citationChen, G.-S., Yu, H.-S., Lan, C.-C. E., Chow, K., Lin, T.-Y., Kok, L.-F., Lu, M.-P., Liu, C.-H., & Wu, M.-T. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07150.x · Cited by 70
Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
Hart, C. A., Brown, M. D., Bagley, S., Sharrard, M., & Clarke, N. W. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602325 · Cited by 68
Pisati, F., Belicchi, M., Acerbi, F., Marchesi, C., Giussani, C. G., Gavina, M., Javerzat, S., Hagedorn, M., Carrabba, G. G., Lucini, V., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1384 · Cited by 55
Lee, C., Kakinuma, T., Wang, J., Zhang, H., Palmer, D. C., Restifo, N. P., & Hwang, S. T. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0310 · Cited by 46
Tavor, S., Petit, I., Porozov, S., Goichberg, P., Avigdor, A., Sagiv, S. P., Nagler, A., Naparstek, E., & Lapidot, T. (2005) · Blood · doi:10.1182/blood-2004-12-4969 · Cited by 39
Andreeff, M., Konoplev, S. N., Wang, R., Zeng, Z., McQueen, T. J., Shi, Y., Medeiros, L. J., Estey, E. H., McCarty, J. M., Elkins, S. L., et al. (2006) · Blood · doi:10.1182/blood.v108.11.568.568 · Cited by 28
Cited by
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Teicher, B. A., & Fricker, S. P. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2329 · Cited by 1,449
Herishanu, Y., Pérez-Galán, P., Liu, D., Biancotto, A., Pittaluga, S., Vire, B., Gibellini, F., Njuguna, N., Lee, E., Stennett, L., et al. (2011) · Blood · doi:10.1182/blood-2010-05-284984 · Cited by 815
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
“Antagonists of CXCR4 can disrupt these interactions, forcing the leukemia cells back into circulation where they are more susceptible to chemotherapeutic drugs [122], and may serve as crucial additions on nanodrugs.”
BackgroundCancer stem cell definitions and terminology: the devil is in the details
Valent, P., Bonnet, D., De Maria, R., Lapidot, T., Copland, M., Melo, J. V., Chomienne, C., Ishikawa, F., Schuringa, J. J., Stassi, G., et al. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3368 · Cited by 692
Metadata
- Authors
- Burger, J. A., & Peled, A.
- Venue
- Leukemia
- Published
- 2008-11-06
- Volume
- 23
- Issue
- 1
- Pages
- 43-52
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2149888039
- Cited by
- 462
- References
- 133
- FWCI
- 16.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.